Atorvastatin attenuates ferroptosis-dependent myocardial injury and inflammation following coronary microembolization via the Hif1a/Ptgs2 pathway

Atorvastatin attenuates ferroptosis-dependent myocardial injury and inflammation following coronary microembolization via the Hif1a/Ptgs2 pathway

Objectives: Coronary microembolization (CME) represents a serious periprocedural complication after percutaneous coronary intervention. Ferroptosis has been identified in multiple cardiovascular diseases. In this study, we aimed to investigate the effects of atorvastatin (ATV) on ferroptosis and inf...

Full description

Bibliographic Details
Main Authors:	Tao Liu, Jin Shu, Yangchun Liu, Jian Xie, Tao Li, Haoliang Li, Lang Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Pharmacology
Subjects:	coronary microembolization ferroptosis inflammation atorvastatin myocardial injury
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1057583/full

Similar Items

Atorvastatin Inhibits Myocardial Apoptosis in a Swine Model of Coronary Microembolization by Regulating PTEN/PI3K/Akt Signaling Pathway
by: Jiangyou Wang, et al.
Published: (2016-01-01)

Levosimendan attenuates myocardial injury induced by coronary microembolization in swine by inhibiting myocardial inflammation and apoptosis
by: Han Chen, et al.
Published: (2019-01-01)

The Involvement of Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN) in the Regulation of Inflammation Following Coronary Microembolization
by: Jiangyou Wang, et al.
Published: (2014-06-01)

Induction of Myocardial PDCD4 in Coronary Microembolization-Related Cardiac Dysfunction: Evidence from a Large-Animal Study
by: Qiang Su, et al.
Published: (2014-08-01)

Human Urinary Kallidinogenase Pretreatment Inhibits Myocardial Inflammation and Apoptosis after Coronary Microembolization by Activating PI3K/Akt/FoxO1 Axis
by: Jian Xie, et al.
Published: (2022-10-01)

Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK/SIRT1/NLRP3 signaling pathway
by: Hongqing Li, et al.
Published: (2024-01-01)

Effects of Trimetazidine on PDCD4/NF-κB/TNF-α Pathway in Coronary Microembolization
by: Qiang Su, et al.
Published: (2017-06-01)

Approaches to classification of microembolic signals in patients recovering from ischemic stroke
by: Ekaterina V. Orlova, et al.
Published: (2023-09-01)

Dynamic changes and the relationship between cardiac function damage and glycogen synthase kinase-3 β expression induced by coronary microembolization in rats
by: Binghui Kong, et al.
Published: (2019-01-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

Microembolism after Endovascular Treatment of Unruptured Cerebral Aneurysms: Reduction of its Incidence by Microcatheter Lumen Aspiration
by: Dae Yoon Kim, et al.
Published: (2015-09-01)

Microembolizations in the Arterial Cerebral Circulation in Patients with Atrial Fibrillation Ablation Using the Cryoballoon Technique—Protocol and Methodology of a Prospective Observational Study
by: Damir Erkapic, et al.
Published: (2023-05-01)

Different effects of air microembolism through patent foramen ovale in patients with migraine: A quantitative electroencephalogram case series
by: Raffaele Ornello, et al.
Published: (2022-12-01)

Protective effects of atorvastatin and quercetin on isoprenaline-induced myocardial infarction in rats
by: Mai A. Zaafan, et al.
Published: (2013-06-01)

Advances in biological markers of ferroptosis in myocardial infarction
by: CHANG Yuchen, LI Jingbo
Published: (2023-04-01)

ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE
by: M. V. Solodun, et al.
Published: (2015-09-01)

Klotho protects against aged myocardial cells by attenuating ferroptosis
by: Xicheng Xiong, et al.
Published: (2023-05-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

Comparative effects of atorvastatin 80 mg and rosuvastatin 40 mg on the levels of serum endocan, chemerin, and galectin-3 in patients with acute myocardial infarction
by: Abdullah Tunçez, et al.
Published: (2019-11-01)

The emerging role of ferroptosis in myocardial fibrosis of atrial fibrillation
by: Honghua Yue, et al.
Published: (2023-02-01)

Melanin nanoparticles alleviate sepsis-induced myocardial injury by suppressing ferroptosis and inflammation
by: Chang Liu, et al.
Published: (2023-06-01)

Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin
by: Samad Golshani, et al.
Published: (2022-01-01)

Attenuation of Low Ambient Temperature-Induced Myocardial Hypertrophy by Atorvastatin via Promoting Bcl-2 Expression
by: Jing Liang, et al.
Published: (2017-01-01)

A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Selim Ahmed, et al.
Published: (2008-04-01)

Can atorvastatin calcium cause asymptomatic hypercalcemia?
by: Suleyman Hilmi Ipekci, et al.
Published: (2014-10-01)

Development and Validation of Robust Ferroptosis-Related Genes in Myocardial Ischemia-Reperfusion Injury
by: Xiuxian Wei, et al.
Published: (2023-08-01)

Association between NLRP3 inflammasome and periprocedural myocardial injury following elective PCI
by: Ao Chen, et al.
Published: (2023-08-01)

Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation
by: José A. Inia, et al.
Published: (2023-04-01)

Atorvastatin-pretreated mesenchymal stem cell-derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA-139-3p/Stat1 pathway
by: Yu Ning, et al.
Published: (2023-03-01)

Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway
by: Yang T, et al.
Published: (2023-08-01)

Ferroptosis in myocardial infarction: not a marker but a maker
by: Xiao-dong Wang, et al.
Published: (2021-04-01)

A One-Step Sample Processing Method in Combination with HPLC-MS/MS for the Simultaneous Quantification of Atorvastatin, Ezetimibe and Three Metabolites including <i>o</i>-Hydroxyl Atorvastatin, <i>p</i>-Hydroxyl Atorvastatin, and Ezetimibe-Glucuronide in Human Plasma
by: T. Nguyen Nguyen Le, et al.
Published: (2023-07-01)

Construction of a ceRNA network of regulated ferroptosis in doxorubicin-induced myocardial injury
by: Hongwei Ye, et al.
Published: (2023-01-01)

Evaluation of the Anti-inflammatory Effects of Atorvastatin on Patients with Rheumatoid Arthritis: A Randomized Clinical Trial
by: Zhaleh Shariati Sarabi, et al.
Published: (2016-08-01)

Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition
by: Weixiang Chen, et al.
Published: (2023-02-01)

AP39 inhibits ferroptosis by inhibiting mitochondrial autophagy through the PINK1/parkin pathway to improve myocardial fibrosis with myocardial infarction
by: Ting Yang, et al.
Published: (2023-09-01)

EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
by: A. N. Meshkov
Published: (2016-01-01)

The Effect of Atorvastatin on the Pancreatic Tissue of Male Rats
by: M Karimian, et al.
Published: (2013-04-01)

Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3/CPT1 pathway
by: Peng Zheng, et al.
Published: (2023-01-01)

Expression pattern and diagnostic value of ferroptosis-related genes in acute myocardial infarction
by: Jiahe Wu, et al.
Published: (2022-11-01)